PALI
Palisade Bio, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.09
+2.20%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 217.28x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.99x
- Price / sales
- 728.45x
- Price / cash flow
- -20.02x
Enterprise value
- Enterprise value
- $239.1M
- EV / sales
- 478.11x
- EV / EBITDA
- -7.20x
- EV / EBIT
- -6.76x
- Market cap
- $364.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026